Corporate

BTI Biotechnology Institute is a Spanish multinational company specialising in biomedicine and biotechnology whose activity focuses on two areas: regenerative medicine and oral implantology.

Dental

Manufacturer of the BTI Implant System, internationally recognised due to their quality and versatility.

Regenerative Medicine

A pioneer in the development of technology related to plasma rich in growth factors, Endoret® (prgf®).

Training

An international reference with a wide range of courses on offer on Oral Implantology and Regenerative Therapies.

Research

Research and innovation, BTI's DNA. Leaders in R&D&i with a translational vision.

Patients

Our research and knowledge in clinical practice at the service of our patients.

Recent activity

News and Novelties

BTI CORE The most effective, profitable and flexible solution
12/03/2020 BTI CORE The most effective, profitable and flexible solution
Endoret® (PRGF®) rewrites the way of treating patients
27/11/2019 Endoret® (PRGF®) rewrites the way of treating patients
Join the SQUARE prosthetic evolution
16/05/2019 Join the SQUARE prosthetic evolution

Events and Training

I Jornada ecografía del pie y tobillo
18/04/2020 I Jornada ecografía del pie y tobillo
Sepes Digital Academy
24/04/2020 Sepes Digital Academy
BTI Day Alemania 2020
25/04/2020 BTI Day Alemania 2020

BTI Channel

BTI UnicCa®, the first implant system on the market to receive the “CleanImplant Foundation” mark

The UnicCa® implant system by BTI was recognised with the CleanImplant Foundation mark, which certifies the purity of the surface of the dental implants by the company from Vitoria.

Go to BTI Channel

And also

Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.